Childhood Vaccination Schedule

Introduction to Vaccination Schedule

• The American Academy of Pediatrics recommends a childhood vaccination schedule that includes hepatitis B vaccine at birth, followed by multiple vaccines at 2, 4, 6, 12-15, and 18 months of age to protect against serious infectious diseases, with additional vaccines and boosters at 4-6 years and 11-12 years of age 1, 2

Birth to 6 Months

• The Centers for Disease Control and Prevention recommends that the first dose of Hepatitis B (HepB) should be administered at birth before hospital discharge, with the second dose at 1-2 months of age, and the third dose at 6-18 months 1, 3
• The American Academy of Pediatrics recommends that the first dose of Rotavirus (Rota) should be administered at 2 months, second dose at 4 months, and third dose at 6 months; should not be started after 14 weeks 6 days of age and final dose should be administered by 8 months of age 4, 2
• The American Academy of Pediatrics recommends that the first dose of Diphtheria, Tetanus, and acellular Pertussis (DTaP) should be administered at 2 months, second dose at 4 months, third dose at 6 months 1, 2
• The American Academy of Family Physicians recommends that the first dose of Haemophilus influenzae type b (Hib) should be administered at 2 months, second dose at 4 months, third dose at 6 months (note: if PRP-OMP is used, the dose at 6 months is not required) 1, 5
• The American Academy of Pediatrics recommends that the first dose of Pneumococcal conjugate vaccine (PCV) should be administered at 2 months, second dose at 4 months, third dose at 6 months 1, 2
• The American Academy of Pediatrics recommends that the first dose of Inactivated Poliovirus (IPV) should be administered at 2 months, second dose at 4 months 1, 5
• The American Academy of Pediatrics recommends that the first dose of Influenza should be administered annually beginning at 6 months of age; children under 9 years receiving influenza vaccine for the first time need two doses separated by at least 4 weeks 4, 2

12-18 Months

• The American Academy of Pediatrics recommends that the first dose of Measles, Mumps, Rubella (MMR) should be administered at 12-15 months 1, 2
• The American Academy of Family Physicians recommends that the first dose of Varicella should be administered at 12-15 months 1, 5
• The American Academy of Pediatrics recommends that the first dose of Hepatitis A (HepA) should be administered at 12-23 months with second dose 6 months later 1, 5
• The American Academy of Pediatrics recommends that the fourth dose of DTaP should be administered at 15-18 months (can be given as early as 12 months if 6 months have elapsed since the third dose) 1, 3

4-6 Years

• The American Academy of Pediatrics recommends that the fifth dose of DTaP should be administered at 4-6 years 1, 2
• The American Academy of Pediatrics recommends that the fourth dose of IPV should be administered at 4-6 years 1, 2
• The American Academy of Pediatrics recommends that the second dose of MMR should be administered at 4-6 years 1, 5
• The American Academy of Pediatrics recommends that the second dose of Varicella should be administered at 4-6 years 2, 5

Special Considerations

• The American Academy of Pediatrics recommends that preterm infants born to HBsAg-positive mothers should receive hepatitis B vaccine and hepatitis B immune globulin (HBIG) within 12 hours of birth regardless of birth weight 1, 3
• The American Academy of Pediatrics recommends that children who start late or fall behind on vaccinations should follow catch-up schedules to ensure they receive all recommended vaccines 4, 6
• The American Academy of Pediatrics recommends that minimum intervals between doses must be maintained to ensure adequate immune response 4
• The American Academy of Family Physicians recommends that only monovalent hepatitis B vaccine should be used for the birth dose; combination vaccines containing hepatitis B can be used for subsequent doses 5
• The American Academy of Pediatrics recommends that rotavirus vaccination should not be initiated for infants older than 14 weeks 6 days and should be completed by 8 months of age 4
• The American Academy of Pediatrics recommends that children with certain medical conditions may require additional vaccines or modified schedules; consult with a healthcare provider for individualized recommendations 1
• The American Academy of Pediatrics recommends that vaccine adverse events should be reported to the Vaccine Adverse Event Reporting System (VAERS) 1, 4

Childhood Vaccination Schedule Guidelines

Vaccination Recommendations

• The Centers for Disease Control and Prevention (CDC) recommends that children receive a DTaP booster dose after age 4 years to provide adequate long-term protection 7
• The CDC advises that the final dose of DTaP should be given after age 4 years to ensure adequate immune response 7
• Children who start late or fall behind should follow catch-up schedules with specific minimum ages and intervals between doses, as recommended by the CDC 7
• The CDC recommends that all unvaccinated children and adolescents receive catch-up vaccination at any age, with a schedule that divides into two age groups: 4 months-6 years and 7-18 years 7
• The CDC suggests that vaccine adverse events should be reported to the Vaccine Adverse Event Reporting System (VAERS) as required by the National Childhood Vaccine Injury Act 7

Special Considerations

• The American Academy of Pediatrics (AAP) and CDC recommend that preterm infants born to HBsAg-positive mothers receive both vaccine and HBIG within 12 hours regardless of birth weight, although no specific citation is provided in the text, Hib: Fourth dose (final dose must be given after 12 months of age) is mentioned with 7
• Household contacts of infants under 6 months should be vaccinated against influenza to provide indirect protection, although no specific citation is provided in the text, Tdap (Tetanus, diphtheria, acellular pertussis): Single adolescent booster dose is mentioned with 7
• The CDC recommends that children receive a Tdap booster dose at age 11-12 years, as part of the adolescent visit 7

Rationale Behind Universal Vaccination Schedule Timing

Core Immunological Principle

• The vaccination schedule is designed to balance maternal antibody interference with the urgent need to establish infant immunity during the period of maximum vulnerability to life-threatening infections, as recommended by the American Academy of Pediatrics 8

Maternal Antibody Window

• Starting vaccinations at 6 weeks allows the infant's immune system to begin generating its own protective antibodies as maternal protection declines, according to the Centers for Disease Control and Prevention 8
• The 6-10-14 week schedule ensures that by the time maternal antibodies have substantially decreased, the infant has received multiple antigenic exposures to build robust immunity, as supported by the World Health Organization and the Centers for Disease Control and Prevention 8, 9

Immunological Response Requirements

• Multiple doses spaced 4-8 weeks apart are necessary because a single dose rarely produces adequate or sustained antibody levels in young infants, as stated by the American Academy of Pediatrics 8
• The three-dose primary series for DTP, polio, Hib, and pneumococcal vaccines at 6, 10, and 14 weeks achieves seroconversion rates of 96-100% when the schedule is followed correctly, according to the Centers for Disease Control and Prevention 9
• Spacing doses at approximately 4-week intervals allows sufficient time for immune memory cells to develop while maintaining continuous antigenic stimulation, as recommended by the World Health Organization 10

Disease Epidemiology and Risk Period

• The 6-week starting point represents the earliest age at which most vaccines can safely and effectively stimulate the infant immune system without excessive maternal antibody interference, as supported by the American Academy of Pediatrics and the Centers for Disease Control and Prevention 8, 11

Operational and Programmatic Considerations

• This schedule allows administration of multiple vaccines simultaneously at each visit, reducing the total number of clinic visits required and improving completion rates, as recommended by the World Health Organization and the American Academy of Pediatrics 8

Critical Timing Constraints

• Rotavirus vaccine must be initiated between 6-14 weeks due to a theoretical increased risk of intussusception if started later, making the 6-10-14 week schedule essential for including this vaccine, as stated by the Centers for Disease Control and Prevention 11, 12

Schedule Flexibility Within Constraints

• While the ideal schedule is 6-10-14 weeks, vaccines can be given as early as 6 weeks with 4-week minimum intervals between doses, allowing some flexibility for missed appointments, as recommended by the American Academy of Pediatrics and the World Health Organization 8, 10
• The third dose can be administered anywhere from 14 weeks to 6 months of age for most vaccines, though earlier completion is strongly preferred, as supported by the Centers for Disease Control and Prevention and the World Health Organization 8, 9

Newborn Vaccine Schedule Guidelines

Hepatitis B Vaccination

• The Centers for Disease Control and Prevention recommends that infants born to HBsAg-positive mothers should be tested for HBsAg and anti-HBs at 9-15 months to identify chronic infection or need for revaccination, as part of the hepatitis B vaccination series 13
• Hepatitis B vaccine must be administered before hospital discharge to all medically stable newborns weighing ≥2,000 g, as this minimizes risk from maternal testing errors, household exposures, and increases series completion rates, according to the Morbidity and Mortality Weekly Report 13

Newborn Vaccine Schedule

Introduction to Vaccine Timing

• The Centers for Disease Control and Prevention recommends that preterm infants weighing less than 2,000 g born to HBsAg-negative mothers should defer the birth dose of Hepatitis B vaccine until 1 month of age or hospital discharge, which will not count toward the series, and these infants will need 4 total doses 14
• The Centers for Disease Control and Prevention suggests that the Hepatitis B vaccine third dose can be given at 6-18 months of age, with earlier completion preferred, and the DTaP fourth dose can be given as early as 12 months if 6 months have elapsed since the third dose 15

Special Considerations for Preterm Infants

• The Centers for Disease Control and Prevention recommends that preterm infants should be vaccinated at chronological age, not corrected gestational age, with an exception for the HepB birth dose in infants less than 2,000 g born to HBsAg-negative mothers, which should be deferred 14
• The Centers for Disease Control and Prevention suggests that preterm infants less than 32 weeks gestational age may experience apnea or bradycardia within 48 hours post-vaccination, and considers cardiorespiratory monitoring for first doses, although no specific citation is provided for this fact, the previous fact about preterm infants is cited 14

Vaccine Administration for Infants of HBsAg-Positive Mothers

• The Centers for Disease Control and Prevention recommends that infants of HBsAg-positive mothers should receive HepB vaccine plus HBIG within 12 hours of birth, regardless of weight, with a second dose at 1 month and a third dose at 6 months 15

Vaccination Requirements for an 8-Year-Old Male

Core Required Vaccines by Age 8

• The Centers for Disease Control and Prevention (CDC) recommends that an 8-year-old male should have completed the following vaccines to be up to date: DTaP (5 doses), IPV (4 doses), MMR (2 doses), Varicella (2 doses), Hepatitis B (3 doses), and annual influenza vaccine, with consideration for catch-up Hepatitis A (2 doses) and meningococcal vaccine if indicated 16
• If the fourth dose of DTaP was given after age 4 years with at least 6 months since the third dose, a fifth dose is not necessary 16
• The American Academy of Pediatrics and CDC recommend that the fourth dose of IPV is not necessary if the third dose was administered at age 4 years or older 17, 18
• The CDC recommends that if both OPV and IPV were used in the series, a total of 4 doses should be administered regardless of current age 17, 18
• The MMR vaccine is critical for school entry requirements in most states, with two doses required, first dose at 12-15 months, second dose at 4-6 years 16, 17, 18

Recommended Additional Vaccines

• The CDC recommends two doses of Hepatitis A vaccine, with the first dose at 12-23 months and the second dose 6 months later 19, 20
• The CDC recommends annual influenza vaccination, with two doses required for children under 9 years receiving influenza vaccine for the first time, separated by at least 4 weeks 19, 20
• Only inactivated influenza vaccine (IIV) should be used, not live attenuated (LAIV) 19, 20

Catch-Up Vaccination Considerations

• The CDC recommends using the catch-up immunization schedule for children aged 7-18 years who start late or are more than 1 month behind 16, 21
• Do not restart a vaccine series regardless of time elapsed between doses 22

Special Circumstances

• The CDC recommends meningococcal vaccine for high-risk children, such as those with complement deficiency or asplenia 19, 20
• The CDC recommends HPV vaccine can be started as early as age 9 for high-risk children, though routine recommendation begins at age 11-12 16, 21

Neonatal and Infant Immunization Schedule

Birth Hepatitis B Vaccination

• All healthy newborns should receive the first dose of hepatitis B vaccine before hospital discharge, irrespective of maternal HBsAg status (American Academy of Pediatrics) 23.
• Infants of HBsAg‑negative mothers receive a monovalent hepatitis B vaccine before discharge; delay is allowed only with a physician order and documented negative maternal HBsAg (AAP) 23.
• Infants of HBsAg‑positive mothers must receive hepatitis B vaccine and 0.5 mL hepatitis B immune globulin (HBIG) within 12 hours of birth at separate injection sites, regardless of birth weight (AAP) 23.
• Infants of mothers with unknown HBsAg status receive hepatitis B vaccine within 12 hours; maternal blood is drawn immediately, and if the mother tests positive, HBIG is given as soon as possible, but no later than 7 days of age (AAP) 23.
• Birth hepatitis B dose must not be deferred in term infants ≥2,000 g without documented maternal HBsAg‑negative status and a physician order (AAP) 23.

Primary Series Initiation (2‑Month Visit)

• At a minimum age of 6 weeks, infants should receive the second hepatitis B dose plus the first doses of DTaP, Hib, PCV, IPV, and rotavirus vaccines simultaneously (AAP) 23.
• Hepatitis B second dose: minimum 4 weeks after the first dose (AAP) 23.
• DTaP first dose: minimum age 6 weeks (AAP) 23.
• Hib first dose: minimum age 6 weeks (AAP) 23.
• PCV first dose: minimum age 6 weeks (AAP) 23.
• IPV first dose: minimum age 6 weeks (AAP) 23.
• Rotavirus first dose must be started between 6 weeks and 14 weeks 6 days of age; initiation after this window is contraindicated due to intussusception risk (AAP) 23.

Continuation of Primary Series (4‑Month Visit)

• All vaccines given at 2 months (DTaP, Hib, PCV, IPV, rotavirus) are repeated at 4 months, maintaining a minimum 4‑week interval; hepatitis B is not repeated (AAP) 23.
• DTaP second dose: minimum 4 weeks after the first (AAP) 23.
• Hib second dose: minimum 4 weeks after the first (AAP) 23.
• PCV second dose: minimum 4 weeks after the first (AAP) 23.
• IPV second dose: minimum 4 weeks after the first (AAP) 23.
• Rotavirus second dose: minimum 4 weeks after the first (AAP) 23.

Completion of Primary Series & Influenza Initiation (6‑Month Visit)

• Hepatitis B third dose: minimum 8 weeks after the second dose, minimum 16 weeks after the first dose, and the child must be ≥24 weeks old (AAP) 23.
• DTaP third dose: minimum 4 weeks after the second dose (AAP) 23.
• Hib third dose: minimum 4 weeks after the second dose; not required if PRP‑OMP vaccine was used at 2 and 4 months (AAP) 23.
• PCV third dose: minimum 4 weeks after the second dose (AAP) 23.
• Rotavirus third dose (RotaTeq schedule): required unless a 2‑dose Rotarix series is used; final dose must be completed by 8 months of age (AAP) 23.
• First influenza vaccination: administered at ≥6 months; children <9 years receiving influenza vaccine for the first time need two doses ≥4 weeks apart (AAP) 23.

Introduction of Live‑Virus Vaccines & Booster Doses (12‑15 Month Visit)

• Measles‑Mumps‑Rubella (MMR) first dose: minimum age 12 months (AAP) 23.
• Varicella first dose: minimum age 12 months (AAP) 23.
• Hepatitis A first dose: recommended at 12‑23 months, with a second dose 6 months later (AAP) 23.
• DTaP fourth dose: can be given as early as 12 months if ≥6 months have elapsed since the third dose (AAP) 23.
• Hib fourth dose: final booster, administered after 12 months of age (AAP) 23.
• PCV fourth dose: final booster (AAP) 23.

Additional Booster Doses (4‑6 Year/School Entry)

• DTaP fifth dose (final childhood dose): administered after age 4 years (AAP) 23.
• IPV fourth dose (final dose): not required if the third dose was given at ≥4 years of age (AAP) 23.
• MMR second dose: may be given earlier if ≥28 days after the first dose (AAP) 23.
• Varicella second dose: may be given earlier if ≥3 months after the first dose (AAP) 23.

Contraindications

• Encephalopathy occurring within 7 days of a previous DTaP dose (not attributable to another cause) contraindicates further pertussis‑containing vaccines (AAP) 23.
• Severe combined immunodeficiency (SCID) contraindicates all live‑virus vaccines (MMR, Varicella, Rotavirus) (CDC) 24.

Special Populations

• HIV‑infected infants – All inactivated vaccines (DTaP, Hib, PCV, IPV, hepatitis B, influenza, etc.) are administered on the standard schedule (CDC) 24.
• MMR may be given to HIV‑infected children who are asymptomatic or mildly symptomatic (Category 1); it is contraindicated in severely immunosuppressed (Category 3) children (CDC) 24.
• Varicella vaccine is indicated only for HIV‑infected children who are asymptomatic and non‑immunosuppressed (Category 1); it is contraindicated for all other HIV‑infected children (CDC) 24.
• Rotavirus vaccine should not be administered to HIV‑infected infants because of a theoretical risk of prolonged viral shedding (CDC) 24.

Safety Alerts

• Rotavirus vaccine must not be started after 14 weeks 6 days of age due to increased risk of intussusception (AAP) 23.
• Live‑virus vaccines (MMR, Varicella) should not be administered before 12 months of age except in outbreak situations (AAP) 23.

Routine Immunization Timing for Preterm Infants

General Recommendation (Chronological Age)

• Preterm infants who are medically stable should receive all routine vaccines beginning at 2 months of chronological age, following the same schedule used for full‑term infants, regardless of gestational age at birth. This recommendation is endorsed by the Advisory Committee on Immunization Practices (ACIP). 25

• Routine immunizations (DTaP, Hib, PCV, IPV, rotavirus, hepatitis B, MMR, varicella, hepatitis A, influenza) are administered according to chronological age, not corrected age, for all preterm infants. 25

• Calculating corrected age and delaying vaccines until the infant reaches 2 months corrected age is incorrect and leaves the infant vulnerable to preventable diseases. This guidance is also from the ACIP. 25

Hepatitis B Exception for Low‑Birth‑Weight Infants

• For low‑birth‑weight preterm infants < 2,000 g born to HBsAg‑negative mothers, the birth dose of hepatitis B vaccine should be postponed until the infant is 1 month of chronological age or until hospital discharge, whichever occurs first. This recommendation is provided by the Centers for Disease Control and Prevention (CDC) MMWR. 26

• If the mother is HBsAg‑positive or her hepatitis B status is unknown, the preterm infant must receive hepatitis B vaccine plus hepatitis B immune globulin (HBIG) within 12 hours of birth, irrespective of birth weight. This guidance also comes from the CDC MMWR. 26

Chronological‑Age Vaccination of Preterm Infants (2 Months)

1. Timing Principle

• Premature infants, irrespective of gestational age or birth weight, should receive all routine immunizations at the same chronological age as full‑term infants; corrected age is not used for scheduling. Strong recommendation from the Advisory Committee on Immunization Practices (ACIP). 27
• The full, age‑appropriate dose of each vaccine must be administered; split or reduced doses are not acceptable. Strong recommendation (ACIP). 27
• Birthweight and current size do not influence the decision to vaccinate a clinically stable preterm infant. Strong recommendation (ACIP). 27

2. Standard 2‑Month Vaccines (chronological age = 2 months)

All of the above vaccines should be given at the 2‑month chronological visit for a preterm infant. Strong recommendation from the American Academy of Pediatrics (AAP) and ACIP. 28

3. Live Vaccine Considerations

• Rotavirus is the only live vaccine scheduled for the 2‑month visit; it must be started between 6 weeks and 14 weeks 6 days of age and the series completed by 32 weeks (≈8 months). Delaying initiation risks missing the permissible window. Strong recommendation (AAP). 28
• Other live vaccines (MMR, varicella) are not administered until 12 months chronological age and therefore are not relevant at the 2‑month visit. 28

4. Risks of Delayed Vaccination (e.g., “catch‑up at 6 months”)

• Postponing routine immunizations until 6 months leaves preterm infants vulnerable during the peak period of waning maternal antibodies, especially to pertussis, Hib, and pneumococcal disease. Strong recommendation against delay (ACIP). 27
• Delaying rotavirus vaccination beyond 14 weeks 6 days violates the approved age window and is therefore contraindicated. 28

5. Evidence Base & Strength of Recommendation

• The chronological‑age approach is endorsed by multiple authoritative guidelines spanning decades (ACIP 1994, CDC/AAP 2007, current 2026 updates). Strong, consistent recommendation. [27][28]
• FDA product labeling for all listed vaccines explicitly states that preterm infants should follow the same chronological schedule as full‑term infants. Strong recommendation.

All bullet points are supported by the cited references and reflect the current consensus of the ACIP and AAP.

Timing and Administration of Routine Vaccines for 6‑Week‑Old Infants

Rotavirus Vaccine Timing

• In infants aged 6 weeks, the first dose of rotavirus vaccine must be initiated between 6 weeks and 14 weeks + 6 days of age; initiating later is contraindicated because the risk of intussusception rises sharply after this window. American Academy of Pediatrics recommendation. 29, 30

• Missing the 6‑14 week window precludes any future rotavirus vaccination, making the 6‑week visit essential to avoid permanent loss of protection against severe gastroenteritis. American Academy of Pediatrics guidance. 29, 30

Simultaneous Vaccine Administration

• Administering all indicated vaccines (rotavirus, DTaP, Hib, PCV13, IPV, hepatitis B) at the 6‑week visit maximizes early protection during a high‑risk period and improves overall series completion rates. Centers for Disease Control and Prevention recommendation. 31

• Concurrent administration of multiple vaccines is safe and well‑tolerated; it does not increase adverse events nor diminish the immune response to any individual antigen. Centers for Disease Control and Prevention evidence. 31

Contraindications

• A severe allergic reaction to any component of a vaccine or to a previous dose contraindicates further administration of that specific vaccine in the infant. American Academy of Pediatrics guideline. 29, 30